Hajra Naz
Pennsylvania-based startup Mosqitter unveiled its AI-powered disease monitoring system at TechCrunch Disrupt 2026 on Tuesday. The company builds chemical-free mosquito traps. It now plans to turn them into a global surveillance network.
How the Traps Work
Mosqitter’s traps lure female mosquitoes. They copy human cues like body heat, skin odor, and light. The flagship Grand model also releases CO₂.. That mimics human breathing. A computer-vision system then identifies the species of each captured mosquito.
CEO Anastasiia Romanova says the process works like “three judges” reaching a verdict. A neural network analyzes each image first. The system then checks results against external datasets. Entomologists validate the findings last.
“We saw an opportunity: If we could catch the female mosquito at the point when she is about to lay eggs, we could potentially reduce the mosquito population and prevent it from growing,” Romanova said. “That’s why we combined elements such as heat, similar to the temperature of human skin; scent that imitates human skin odor; and light. In the Grand model, which is the company’s highest-end offering, “we also use CO₂ to imitate human breathing.”
The Febris Platform
This data now feeds into Febris, the company’s new monitoring platform. Febris assesses disease spread risks. It bases that on which species it finds in a given area. Romanova stressed one point. “Febris does not diagnose disease.” Instead, it flags when a high-risk species appears in a region.
The platform launches next month. It targets governments, airports, and public health agencies.
Growth and Clients
Mosqitter runs over 5,000 devices across five continents. That’s a sharp rise from just 250 units in 2022. Its clients include Marriott, Wyndham, Hard Rock, and Disney properties. It also works with the UK Health Security Agency. Together, they’re deploying Febris at Heathrow and Gatwick airports. Brazil, India, Nigeria, and Greece are key markets too.
Read More: Anthropic Reveals Its Biology Lab Has Already Found Something Important
Business Outlook
Mosqitter expects over $1 million in revenue for 2026. It projects that its Febris data business could top $3.5 million next year. The company has raised $1.9 million so far. It now seeks $5 million more across two tranches. It also graduated from the Techstars accelerator.
Why the Timing Matters
Mosquito-borne diseases keep rising worldwide. The WHO reports that global dengue cases jumped from 6.5 million in 2023 to a record 14.6 million in 2024. Rising temperatures and increased global travel continue to expand the areas where disease-carrying mosquitoes can live.
Pricing
Mosqitter sells its Mini trap for $199. The Grand model costs $1,999. Both are sold in the United States through Amazon and the company’s website.
